Guy's & St Thomas' Foundation

Guy's & St Thomas' Foundation

Founded in 2014 as an independent charity, Guy's & St Thomas' Foundation traces its assets to historic endowments tied to the Guy's and St Thomas' hospitals. Under CEO Laurie Lee and CIO Emma Davies, the foundation operates outside the NHS balance sheet, managing its own endowment to fund both health-impact grants and hospital-related capital projects. It maintains close operating ties with Guy's and St Thomas' NHS Foundation Trust and research partner King's College London. The endowment pursues a hybrid approach, mixing institutional fund commitments with direct investments and substantial real-asset holdings in London's SE1 corridor. The listed portfolio spans venture capital, buyout, growth, private credit, secondaries, and special situations. Direct property assets form a distinctive anchor: holdings include Becket House in Westminster, the mixed-use Orchard Lisle and Iris Brook Houses near London Bridge, and the Royal Street development site in Lambeth. The foundation co-develops the Snowsfields Quarter life sciences hub alongside Oxford Properties, while also partnering with Stanhope PLC on Royal Street. The agricultural holdings portfolio extends the real-asset footprint across the United Kingdom. In recent years, the foundation has committed to restructuring its investment office to support the dual mandate of return generation and measurable health impact. A broader team of investment professionals manages the pooled endowment, with the foundation positioning itself as a founding partner of SC1, the South London life sciences innovation district. The foundation is a member of the UN Global Compact, Climate Action 100+, and UKSIF, and it co-founded the Long Term Investors for People's Health (LIPH) global alliance. The foundation's architecture differs from standard NHS-linked charities because it operates an independent, fully discretionary endowment with a dedicated CIO — a structure that resembles a major US medical foundation more than a typical UK hospital charity. Its ability to act as a developer, direct investor, and grantmaker from a single balance sheet gives it a multi-tool posture rarely seen among UK health foundations.